Evidence-based management of ST-segment elevation myocardial infarction (STEMI): Latest guidelines of the European Society of Cardiology (ESC) 2010;Evidenzbasiertes Vorgehen beim ST-Strecken-Hebungsinfarkt (STEMI): Neueste Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) 2010

Herz

Volumn 35, Issue 8, 2010, Pages 558-565

  Silber, S ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anticoagulants; Emergency medical service; Myocardial infarction; Platelet aggregation inhibitors; Reperfusion; Vascular procedures

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CYTOCHROME P450 2C19; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PRASUGREL; THIENOPYRIDINE DERIVATIVE;

ACUTE HEART INFARCTION; ARTICLE; BARE METAL STENT; BLOOD CLOT LYSIS; CORONARY REPERFUSION; DRUG ELUTING STENT; EMERGENCY HEALTH SERVICE; EUROPE; EVIDENCE BASED PRACTICE; GERMANY; HEART INFARCTION SIZE; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; LOADING DRUG DOSE; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; THROMBOCYTE AGGREGATION; THROMBUS ASPIRATION;

AFTERCARE; ANTICOAGULANTS; CARDIOVASCULAR AGENTS; COMBINED MODALITY THERAPY; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; EMERGENCY SERVICE, HOSPITAL; EUROPE; EVIDENCE-BASED MEDICINE; HUMANS; LIFE STYLE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PIPERAZINES; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; THIOPHENES; THROMBOLYTIC THERAPY; TICLOPIDINE; TIME FACTORS;

EID: 79151481385     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-010-3401-8     Document Type: Article

References (19)

1. Statistisches Bundesamt. http://www.destatis.de
2. Eagle KA, Montoye CK, Riba AL, et al. (2005) Guideline-based standardized care is associated with substantially lower mortality in medicare patients with acute myocardial infarction: The American College of Cardiology s Guidelines Applied in Practice (GAP) Projects in Michigan. J Am Coll Cardiol 46:1242-1248
3. Deutsche Gesellschaft für Kardiologie. http://www.dgk.org
4. Werf F van de, Bax J, Betriu A, et al. (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 29:2909-2945
5. Silber S, Albertsson P, Aviles FF, et al. (2005) Guidelines for percutaneous coronary interventions: the Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26:804-847
6. Wijns W, Kolh P, Danchin N, et al. (2010) Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 31(20):2501-2555
7. Silber S, Borggrefe M, HasenfuAY G, et al. (2010) Kommentare zu den Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zur Diagnostik und Therapie von Patienten mit ST-Streckenhebungsinfarkt (STEMI). Kardiologe 4:84-92
8. Terkelsen CJ, Sarensen JT, Maeng M, et al. (2010) System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA 304:763-771
9. Deutsche Herzstiftung. http://www.herzstiftung.de
10. Widimsky P, Wijns W, Fajadet J, et al. (2010) Reperfusion therapy for ST-elevation acute myocardial infarction in Europe: Description of the current situation in 30 countries. Eur Heart J 31:943-957
11. Kalla K, Christ G, Karnik R, et al. (2006) Implementation of guidelines improves the standard of care: the Viennese Registry on Reperfusion Strategies in ST-Elevation Myocardial Infarction (Vienna STEMI Registry). Circulation 113:2398-2405
12. Zahn R, Schiele R, Schneider S, et al. (2000) Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR). J Am Coll Cardiol 36:2064-2071
13. Busk M, Kaltoft A, Nielsen SS, et al. (2009) Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for 12 h vs. 12-72 h. Eur Heart J 30: 1322-1330
14. Schömig A, Mehilli J, Antoniucci D, et al. (2005) Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA 293:2865-2872
15. Montalescot G, Wiviott SD, Braunwald E, et al. (2009) Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): Double-blind, randomised controlled trial. Lancet 373:723-731
16. Stone GW, Witzenbichler B, Guagliumi G, et al. (2008) Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 358:2218-2230
17. Mehran R, Lansky AJ, Witzenbichler B, et al. (2009) Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet 374:1149-1159
18. Vlaar PJ, Svilaas T, Horst IC van der, et al. (2008) Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet 371:1915-1920
19. Piscione F, Danzi GB, Cassese S, et al. (2010) Multicentre experience with MGuard™ net protective stent in ST-elevation myocardial infarction: safety, feasibility, and impact on myocardial reperfusion. Catheter Cardiovasc Interv 75:715-721